FBRX
Price
$76.99
Change
+$0.02 (+0.03%)
Updated
Aug 26 closing price
Capitalization
1.63B
69 days until earnings call
Intraday BUY SELL Signals
QSI
Price
$0.78
Change
+$0.01 (+1.30%)
Updated
Sep 8, 03:01 PM (EDT)
Capitalization
167.67M
64 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FBRX vs QSI

FBRX vs QSI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
FBRX vs. QSI commentary
Sep 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBRX is a Hold and QSI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2026
Stock price -- (FBRX: $76.99 vs. QSI: $0.77)
Brand notoriety: FBRX and QSI are both not notable
FBRX represents the Biotechnology, while QSI is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: FBRX: 64% vs. QSI: 32%
Market capitalization -- FBRX: $1.63B vs. QSI: $167.67M
FBRX [@Biotechnology] is valued at $1.63B. QSI’s [@Medical/Nursing Services] market capitalization is $167.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.42B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $187.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBRX’s FA Score shows that 0 FA rating(s) are green whileQSI’s FA Score has 0 green FA rating(s).

  • FBRX’s FA Score: 0 green, 5 red.
  • QSI’s FA Score: 0 green, 5 red.
According to our system of comparison, FBRX is a better buy in the long-term than QSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBRX’s TA Score shows that 3 TA indicator(s) are bullish while QSI’s TA Score has 5 bullish TA indicator(s).

  • FBRX’s TA Score: 3 bullish, 2 bearish.
  • QSI’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, QSI is a better buy in the short-term than FBRX.

Price Growth

FBRX (@Biotechnology) experienced а 0.00% price change this week, while QSI (@Medical/Nursing Services) price change was -1.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.98%. For the same industry, the average monthly price growth was +7.31%, and the average quarterly price growth was +2521.70%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +12.52%. For the same industry, the average monthly price growth was +8.35%, and the average quarterly price growth was +2.42%.

Reported Earning Dates

FBRX is expected to report earnings on Nov 16, 2026.

QSI is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (+2.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical/Nursing Services (+12.52% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FBRX($1.63B) has a higher market cap than QSI($168M). FBRX YTD gains are higher at: 182.325 vs. QSI (-30.364). FBRX has higher annual earnings (EBITDA): -76.9M vs. QSI (-90.37M). QSI has more cash in the bank: 112M vs. FBRX (58.2M). QSI has higher revenues than FBRX: QSI (1.61M) vs FBRX (0).
FBRXQSIFBRX / QSI
Capitalization1.63B168M973%
EBITDA-76.9M-90.37M85%
Gain YTD182.325-30.364-600%
P/E RatioN/AN/A-
Revenue01.61M-
Total Cash58.2M112M52%
Total DebtN/A3.25M-
FUNDAMENTALS RATINGS
FBRX vs QSI: Fundamental Ratings
FBRX
QSI
OUTLOOK RATING
1..100
506
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3464
P/E GROWTH RATING
1..100
4086
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QSI's Valuation (45) in the null industry is somewhat better than the same rating for FBRX (97). This means that QSI’s stock grew somewhat faster than FBRX’s over the last 12 months.

QSI's Profit vs Risk Rating (100) in the null industry is in the same range as FBRX (100). This means that QSI’s stock grew similarly to FBRX’s over the last 12 months.

QSI's SMR Rating (98) in the null industry is in the same range as FBRX (100). This means that QSI’s stock grew similarly to FBRX’s over the last 12 months.

FBRX's Price Growth Rating (34) in the null industry is in the same range as QSI (64). This means that FBRX’s stock grew similarly to QSI’s over the last 12 months.

FBRX's P/E Growth Rating (40) in the null industry is somewhat better than the same rating for QSI (86). This means that FBRX’s stock grew somewhat faster than QSI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FBRXQSI
RSI
ODDS (%)
N/A
Bullish Trend 7 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
81%
Momentum
ODDS (%)
Bullish Trend 5 days ago
73%
Bearish Trend 5 days ago
87%
MACD
ODDS (%)
Bearish Trend 5 days ago
80%
Bullish Trend 5 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
73%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
71%
Bullish Trend 5 days ago
81%
Advances
ODDS (%)
Bullish Trend 14 days ago
76%
Bullish Trend 19 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
FBRX
Daily Signal:
Gain/Loss:
QSI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ZSCIX42.930.29
+0.68%
Zacks Small-Cap Core Institutional
JGSMX26.690.09
+0.34%
JPMorgan Small Cap Growth R6
USMIX24.670.01
+0.04%
Victory Extended Market Index
SJGAX35.83-0.02
-0.06%
Steward Large Cap Growth A
JABLX53.77-0.07
-0.13%
Janus Henderson VIT Balanced Instl

FBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBRX has been loosely correlated with QSI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if FBRX jumps, then QSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBRX
1D Price
Change %
FBRX100%
N/A
QSI - FBRX
34%
Loosely correlated
+0.66%
AXON - FBRX
31%
Poorly correlated
-4.18%
ANTX - FBRX
29%
Poorly correlated
-1.01%
ARRY - FBRX
28%
Poorly correlated
+1.32%
CLNN - FBRX
27%
Poorly correlated
-3.63%
More